Medication info

Mythorin Tablets 10/20 milligrams

Prescription medicationTabletOralExpired
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
IQURE Co., Ltd.
Appearance
White to off-white, bilaterally convex rectangular tablets
Packaging
Domestic use - 30 tablets/PTP [(10 tablets/PTPX3)]
Approval status
Expired

MFDS item code 202002325 · Approved 2020.04.02

This product's status changed to Expired on 2025.04.02. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Take this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg once daily. The generally recommended starting dose is 10/20mg once daily. For patients who require less LDL cholesterol reduction, treatment may be started at 10/10mg once daily. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not available or effective. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use caution and monitor these patients closely when administering higher doses of this medicine (see 5. General Precautions under Precautions for Use). Administration to older adults No dose adjustment is necessary in older adults. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
IQURE Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
View approved original text

This medication helps control blood cholesterol and related lipid levels in patients with primary hypercholesterolemia, mixed hyperlipidemia, and homozygous familial hypercholesterolemia. It is particularly effective in lowering total cholesterol, LDL cholesterol, ApoB protein, and triglyceride levels, while increasing HDL cholesterol. When used in conjunction with dietary therapy, it improves lipid levels and can be administered as an adjunctive therapy when other treatments are ineffective. Care should also be taken when using it in patients at high risk for atherosclerotic vascular diseases due to hypercholesterolemia. Furthermore, secondary causes such as diabetes and hypothyroidism should be assessed and treated if necessary before administration, and systematic lipid testing and management are essential. This medication is used as an adjunct to dietary therapy to improve blood lipid levels and treat cholesterol-related diseases.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Take this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg once daily. The generally recommended starting dose is 10/20mg once daily. For patients who require less LDL cholesterol reduction, treatment may be started at 10/10mg once daily. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not available or effective. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use caution and monitor these patients closely when administering higher doses of this medicine (see 5. General Precautions under Precautions for Use). Administration to older adults No dose adjustment is necessary in older adults. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This medication can cause serious muscle-related side effects, such as myopathy and rhabdomyolysis; therefore, patients should inform their doctor immediately if they experience muscle pain or weakness during treatment. Particularly, the risk of these side effects may increase when taken at high doses or in combination with certain medications, so caution is needed. This medication is not to be administered to patients with liver dysfunction or active liver disease, pregnant or nursing women. Additionally, it should not be combined with strong CYP3A4 inhibitors such as certain antifungals, antibiotics, antiviral agents, gemfibrozil, cyclosporine, or Danazol. Patients with genetic issues like lactose intolerance should not take this medication. Care should be taken when using this medication in patients with myasthenia gravis or ocular myasthenia gravis, and discontinuation is advised if symptoms worsen. Regular liver function tests and muscle-related testing are important during the treatment with this medication. Women planning for pregnancy or who may become pregnant should consult their doctor before taking this medication and must discontinue it during pregnancy. This medication is only to be used with limitations in children and adolescents and is not recommended for children under 10 years of age. Elderly patients may also be more sensitive to this medication, so caution is required during administration. It is advisable to avoid excessive consumption of grapefruit juice while taking this medication, and when starting new medications, it is essential to inform healthcare professionals about the current use of this medication. In cases of overdose, there are no specific antidotes; therefore, it is crucial to visit a medical institution immediately for appropriate treatment.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 102 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • sensory disturbances
  • depression
  • cholelithiasis
  • cholecystitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reactions with systemic symptoms
  • erythema multiforme
  • liver damage
  • weakness
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • itching
  • rash
  • muscle cramps
  • specific cranial nerve dysfunction
  • taste disturbance
  • ophthalmoplegia
  • facial paresis
  • tremor
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • memory impairment
  • forgetfulness
  • amnesia
  • memory disorders
  • confusion
  • interstitial lung disease
  • angioedema
  • lupus-like erythema
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • arthritis
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • cholestatic jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • alopecia
  • various skin changes
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle paralysis
  • anemia
  • increased aminotransferase levels
  • elevated ALP
  • increased ɤ-GT
  • elevated bilirubin levels
  • thyroid dysfunction
  • increased HbA1c
  • increased fasting blood glucose levels
  • edema
  • thirst
  • facial swelling
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucus stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to keep the storage temperature between 1 degree and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

White to off-white, bilaterally convex rectangular tablets

Package unit

Domestic use - 30 tablets/PTP [(10 tablets/PTPX3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.